In EMT‐6 tumor bearing mice, membranous GRP78 expression on cancer cells (CD45−EpCAM+) significantly reduced after therapy (Figure 2J), and negatively correlated with serum sGRP78 concentration (Figure 2K). This evidence concerns the gene HSPA5 and cancer.